Fjarde AP Fonden Fourth Swedish National Pension Fund Acquires 20,700 Shares of The Cooper Companies, Inc. $COO

Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 71.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 49,720 shares of the medical device company’s stock after purchasing an additional 20,700 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Cooper Companies were worth $3,555,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. New York Life Investment Management LLC lifted its stake in Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares in the last quarter. Root Financial Partners LLC raised its holdings in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the period. Allworth Financial LP raised its holdings in shares of Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after acquiring an additional 167 shares during the period. Blue Trust Inc. lifted its position in Cooper Companies by 13.9% in the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after acquiring an additional 185 shares in the last quarter. Finally, SJS Investment Consulting Inc. lifted its position in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 187 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on COO. Stifel Nicolaus lowered their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a report on Friday, June 5th. Robert W. Baird reduced their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. Needham & Company LLC decreased their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research note on Wednesday, May 27th. Finally, BNP Paribas Exane reduced their price target on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research report on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $81.31.

Cooper Companies Trading Up 1.9%

Cooper Companies stock opened at $73.97 on Tuesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The stock has a 50-day simple moving average of $64.66 and a 200 day simple moving average of $73.26. The stock has a market capitalization of $14.43 billion, a P/E ratio of 61.99, a PEG ratio of 1.94 and a beta of 0.84. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the previous year, the company posted $0.96 EPS. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.